THE RENAL FUNCTIONAL AND STRUCTURAL CONSEQUENCES OF CORTICOSTEROID AND ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR THERAPY IN CHRONIC PUROMYCIN AMINONUCLEOSIDE NEPHROPATHY

被引：7

作者：

TRACHTMAN, H

DELPIZZO, R

VALDERRAMA, E

GAUTHIER, B

机构：

[1] Department of Pediatrics (Division of Nephrology, Schneider Children's Hospital, Long Island Campus for the Albert Einstein College of Medicine, New Hyde Park, 11042, NY

[2] Department of Pathology, Schneider Children's Hospital, Long Island Campus for the Albert Einstein College of Medicine, New Hyde Park, 11042, NY

来源：

PEDIATRIC NEPHROLOGY | 1990年 / 4卷 / 05期

关键词：

PUROMYCIN; STEROID; ANGIOTENSIN-CONVERTING ENZYME INHIBITOR; GLOMERULOSCLEROSIS;

D O I：

10.1007/BF00869832

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

Glomerular diseases are characterized by increased urinary protein excretion. Treatment of this abnormality frequently involves administration of corticosteroids and angiotensin-converting enzyme inhibitors. There has been much recent interest in the potential impact of these drugs on progressive renal dysfunction, since they have opposing effects on intraglomerular hemodynamics. Therefore, we investigated the effect of methylprednisolone or captopril treatment on animals with chronic puromycin aminonucleoside nephropathy. In rats given a single injection of puromycin aminonucleoside, 15 mg/100 g body weight, both methylprednisolone and captopril significantly reduced proteinuria at 6 months [83 +/- 14 untreated (n = 7), 34 +/- 6 with methylprednisolone (n = 8), and 6 +/- 1 mg/24 h with captopril (n = 5), P < 0.001]. Segmental glomerulosclerosis occurred with equal frequency in the untreated (7.8 +/- 2.3%) and methylprednisolone-treated rats (5.0 +/- 1.11%), but was significantly reduced by the administration of captopril (1.0 +/- 0.5%, P < 0.001). We conclude that in chronic puromycin aminonucleoside nephropathy, treatment with corticosteroids reduces proteinuria without increasing the incidence of segmental glomerulosclerosis. Therapy with an angiotensin-converting enzyme inhibitor substantially decreases proteinuria lessens the severity of glomerular scarring.

引用

页码：501 / 504

页数：4

共 17 条

[1] Brenner B.M., Nephron adaptation to renal injury or ablation, Am J Physiol, 249, pp. F324-F337, (1985)
[2] Hostetter T.H., Olson J.L., Rennke H.G., Venkatachalam M.A., Brenner B.M., Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation, Am J Physiol, 241, pp. F85-F93, (1981)
[3] Zatz R., Meyer T.W., Noddin J.L., Rennke H.G., Brenner B.M., Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic nephropathy, Proc Natl Acad Sci USA, 82, pp. 5963-5967, (1985)
[4] Anderson J.J., Brenner B.M., Effects of aging on the renal glomerulus, Am J Med, 80, pp. 435-442, (1986)
[5] Grond J., Weenig J.J., Elema J.D., glomerular sclerosis in nephrotic rats: comparison of the long-term effects of adriamycin and aminonucleoside, Lab Invest, 51, pp. 277-285, (1984)
[6] Anderson S., Meyer T.W., Rennke H.G., Brenner B.M., Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass, J Clin Invest, 76, pp. 612-619, (1985)
[7] Zatz R., Dunn B.R., Meyers T.W., Anderson S., Rennke H.G., Brenner B.M., Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension, J Clin Invest, 77, pp. 1925-1930, (1986)
[8] Garcia D.L., Anderson S.J., Rennke H.G., Brenner B.M., Hemodynamic basis of glucocorticoid-induced acceleration of glomerular injury in rats with renal ablation, J Clin Invest, 80, pp. 867-874, (1987)
[9] Baylis C., Brenner B.M., Mechanism of the glucocorticoid-induced increase in glomerular filtration rate, Am J Physiol, 234, pp. F166-F170, (1978)
[10] Trachtman H., Zavilowitz B., Bennett B., Goldsmith D.I., The effect of captopril on urinary protein excretion in puromycin aminonucleoside nephrosis in rats, Pediatr Res, 9, pp. 828-834, (1985)

← 1 2 →